glp 1 and cannabinoids IUPHAR review – Glucagon-like peptide-1 (GLP-1) substance use disorders: An emerging pharmacotherapeutic target IUPHAR review – Glucagon-like peptide-1
Description
Family physicians play a critical role in guiding patients through the complexities of injectable weight loss medication use and discontinuation.
Health Canada is warning people not to buy or use fake or unauthorized versions of GLP-1 drugs such as semaglutide, the active ingredient in Ozempic and Wegovy
Care led by Local AFC Clinicians&ZeroWidthSpace
Who Is a Good Candidate for Tirzepatide Injections
Three new studies suggest GLP-1 drugs may reduce cancer risk and improve outcomes.
Anyone looking to improve digestion + metabolism naturally
